+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Avibactam"

Antibiotics Market Report 2025 - Product Thumbnail Image

Antibiotics Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Antibiotic Resistance Market Report 2025 - Product Thumbnail Image

Antibiotic Resistance Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Avibactam is a non-β-lactam β-lactamase inhibitor used in combination with antibiotics to treat infections caused by bacteria. It is used in combination with antibiotics to treat infections caused by bacteria that produce certain types of β-lactamases, enzymes that can inactivate certain antibiotics. Avibactam works by blocking the action of these enzymes, allowing the antibiotic to work more effectively. Avibactam is used in combination with antibiotics to treat a variety of infections, including urinary tract infections, skin and soft tissue infections, and pneumonia. Avibactam is a relatively new class of antibiotics, and is currently used in combination with other antibiotics to treat a variety of infections. It is an important tool in the fight against antibiotic resistance, as it helps to prevent bacteria from becoming resistant to antibiotics. Some companies in the Avibactam market include AstraZeneca, Merck, Pfizer, and Allergan. Show Less Read more